Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06816966 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC

Study acronym: CISART
StatusEnrolling by Invitation
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study is a prospective, single-arm, phase Ⅱ trial evaluating the safety and efficacy of Chemotherapy-immunotherapy-based split-course adaptive hypofractionated radiotherapy for extensive-stage SCLC
Trial Details
NCT Number NCT06816966
Lead Sponsor Fujian Medical University Union Hospital
Conditions
(from sponsor)		 Small-cell Lung Cancer
Related terms Small Cell Lung Carcinoma
Enrollment 35 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov